Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Medullary Thyroid Cancer
Related studies linked through entity extraction aliases.
18F-Fluorocholine PET/CT in Medullary Thyroid Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
- Status
- COMPLETED
- Phase
- NA
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer
- Status
- TERMINATED
- Phase
- NA
68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Radiolabeled Molecules for Medullary Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Vandetanib Risk Minimisation Effectiveness
- Status
- COMPLETED
- Phase
- N/A
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Natural History Study of Children and Adults With Medullary Thyroid Cancer
- Status
- RECRUITING
- Phase
- N/A
SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment
- Status
- COMPLETED
- Phase
- PHASE3
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE2